These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11014700)

  • 1. Causes of lability in PTH values.
    Indridason OS
    Semin Dial; 2000; 13(5):337. PubMed ID: 11014700
    [No Abstract]   [Full Text] [Related]  

  • 2. [Parathyroid hormone values in patients on chronic dialysis treatment].
    Mushmov D; Milkov V; Kiriakov Z; Zakharieva B
    Vutr Boles; 1986; 25(3):59-62. PubMed ID: 3765580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioimmunoassay of carboxyl and amino terminal fragments of parathyroid hormone for the evaluation of secondary hyperparathyroidism in chronic renal failure.
    Zanella MT; Silva MC; Peres RB; Ferreira SR; Draibe SA; Vieira JG
    Braz J Med Biol Res; 1990; 23(3-4):235-43. PubMed ID: 2094538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Tentori F; Blayney MJ; Albert JM; Gillespie BW; Kerr PG; Bommer J; Young EW; Akizawa T; Akiba T; Pisoni RL; Robinson BM; Port FK
    Am J Kidney Dis; 2008 Sep; 52(3):519-30. PubMed ID: 18514987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study.
    Fernández-Martín JL; Martínez-Camblor P; Dionisi MP; Floege J; Ketteler M; London G; Locatelli F; Gorriz JL; Rutkowski B; Ferreira A; Bos WJ; Covic A; Rodríguez-García M; Sánchez JE; Rodríguez-Puyol D; Cannata-Andia JB;
    Nephrol Dial Transplant; 2015 Sep; 30(9):1542-51. PubMed ID: 25920921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variability in calcium, phosphorus, and parathyroid hormone in patients on hemodialysis.
    Levitt H; Smith KG; Rosner MH
    Hemodial Int; 2009 Oct; 13(4):518-25. PubMed ID: 19758299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of reduced dialysate calcium on mineral metabolism in hemodialysis patients].
    Fujimori A; Yorifuji M; Sakai M; Fukagawa M
    Clin Calcium; 2005 Sep; 15 Suppl 1():121-4; discussion 124. PubMed ID: 16272643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism.
    Lindberg JS; Moe SM; Goodman WG; Coburn JW; Sprague SM; Liu W; Blaisdell PW; Brenner RM; Turner SA; Martin KJ
    Kidney Int; 2003 Jan; 63(1):248-54. PubMed ID: 12472790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of parathyroid function in patients with a short history of hemodialysis.
    Nishi H; Sato T; Kurihara T; Kurosawa T; Fukagawa M
    Ther Apher Dial; 2005 Feb; 9(1):39-43. PubMed ID: 15828904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES Study.
    Naves-Díaz M; Passlick-Deetjen J; Guinsburg A; Marelli C; Fernández-Martín JL; Rodríguez-Puyol D; Cannata-Andía JB
    Nephrol Dial Transplant; 2011 Jun; 26(6):1938-47. PubMed ID: 20513773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of sevelamer hydrochloride on serum concentration of whole (1-84) and N-terminally truncated (7-84) parathyroid hormone fragments in hemodialysis uremic patients.
    Chudek J; Piecha G; Kokot F; Wiecek A
    J Nephrol; 2003; 16(5):710-5. PubMed ID: 14733418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Drug Effects on Serum Parathyroid Hormone, Phosphorus, and Calcium Levels With Mortality in CKD: A Meta-analysis.
    Palmer SC; Teixeira-Pinto A; Saglimbene V; Craig JC; Macaskill P; Tonelli M; de Berardis G; Ruospo M; Strippoli GF
    Am J Kidney Dis; 2015 Dec; 66(6):962-71. PubMed ID: 26003472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D compounds for people with chronic kidney disease requiring dialysis.
    Palmer SC; McGregor DO; Craig JC; Elder G; Macaskill P; Strippoli GF
    Cochrane Database Syst Rev; 2009 Oct; (4):CD005633. PubMed ID: 19821349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes of serum calcium, phosphorus, and parathyroid hormone concentrations and ocular findings among patients undergoing hemodialysis.
    Pakdel F; Samimagham H; Shafaroodi A; Sheikhvatan M
    Saudi J Kidney Dis Transpl; 2011 Nov; 22(6):1142-8. PubMed ID: 22089771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study.
    Slinin Y; Foley RN; Collins AJ
    J Am Soc Nephrol; 2005 Jun; 16(6):1788-93. PubMed ID: 15814832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cinacalcet (KRN1493) effectively decreases the serum intact PTH level with favorable control of the serum phosphorus and calcium levels in Japanese dialysis patients.
    Fukagawa M; Yumita S; Akizawa T; Uchida E; Tsukamoto Y; Iwasaki M; Koshikawa S;
    Nephrol Dial Transplant; 2008 Jan; 23(1):328-35. PubMed ID: 17717030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma parathormone, calcium and phosphorus in patients with renal osteodystrophy undergoing chronic hemodialysis.
    Genuth SM; Sherwood LM; Vertes V; Leonards JR
    J Clin Endocrinol Metab; 1970 Jan; 30(1):138-40. PubMed ID: 5409532
    [No Abstract]   [Full Text] [Related]  

  • 18. [The calcium-phosphorus balance and parathormone behavior in 7 patients treated with integral hemofiltration].
    Civati G; Guastoni C; Perego A; Galato R; Brando B; Grillo C; Surian M; Colussi G; Teatini U; Minetti L
    Minerva Nefrol; 1981; 28(2):171-4. PubMed ID: 7290521
    [No Abstract]   [Full Text] [Related]  

  • 19. CKD-MBD: comfort in the trough of the U.
    Cunningham J; Silver J
    Nephrol Dial Transplant; 2011 Jun; 26(6):1764-6. PubMed ID: 21551089
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of oral base therapy on serum ionized calcium, phosphorus and parathyroid hormone in chronic hemodialysis patients.
    Caruana RJ; Weinstein RS; Campbell HT; Chaudhary BA; Smith KL; Kurunsaari KM
    Int J Artif Organs; 1989 Dec; 12(12):778-81. PubMed ID: 2559040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.